Cargando…

Screening for antibodies to HLA class I in apheresis donors following Covid‐19 or SARS-CoV-2 vaccination

Transfusion of HLA-specific antibodies may play a role in induction of TRALI, the transfusion complication responsible for most transfusion-related deaths. In Oslo, we screen our apheresis donors and defer HLA-immunized donors from donation of plasma-rich blood components. During the second year of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nissen-Meyer, Lise Sofie H., Czapp, Elzbieta, Naper, Christian, Jensen, Tore, Boulland, Line M.L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425701/ https://www.ncbi.nlm.nih.gov/pubmed/36089469 http://dx.doi.org/10.1016/j.transci.2022.103567

Ejemplares similares

Presensitization revisited: pitfalls of vascular allografts in transplant candidates
por: Boulland, Line M. L., et al.
Publicado: (2014)

Sero-prevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Norway, winter/spring 2021
por: Hvalryg, Marte, et al.
Publicado: (2021)

Effect of Apheresis for ABO and HLA Desensitization on Anti-Measles Antibody Titers in Renal Transplantation
por: Schönermarck, Ulf, et al.
Publicado: (2011)

Apheresis Efficacy and Tolerance in the Setting of HLA-Incompatible Kidney Transplantation
por: Noble, Johan, et al.
Publicado: (2021)

SARS-COV-2 Triggers the Development of Class I and Class II HLA Antibodies in Recovered Convalescent Plasma Donors
por: Dada, Ashraf, et al.
Publicado: (2022)

Do highly transmissible omicron subtypes BA.4/BA.5 have any impact on the HLA class I /II antibodies of apheresis donors, and could mucosal omicron-specific vaccines prevent transmissibility and provide more durable protection?
por: Seghatchian, Jerard
Publicado: (2022)

Preformed Donor-specific Antibodies Against HLA Class II and Graft Outcomes in Deceased-donor Kidney Transplantation
por: Uffing, Audrey, et al.
Publicado: (2019)

Need for plateletpheresis procedure with voluntary regular apheresis donors: An experience
por: Shah, Ripal J., et al.
Publicado: (2018)

The kinetics of donor HLA class I-specific antibody absorption following a combined split liver and kidney transplant
por: Key, Tim, et al.
Publicado: (2010)

Evaluation of bacterial inactivation in random donor platelets and single-donor apheresis platelets by the INTERCEPT blood system
por: Makroo, Raj Nath, et al.
Publicado: (2018)

Upper-extremity Deep Vein Thrombosis Complicating Apheresis in a Healthy Donor
por: Haba, Yuichiro, et al.
Publicado: (2017)

LDL Apheresis and Lp (a) Apheresis: A Clinician’s Perspective
por: Kayikcioglu, Meral
Publicado: (2021)

Class and Kinetics of Weakly Reactive Pretransplant Donor-specific HLA Antibodies Predict Rejection in Kidney Transplant Recipients
por: Morrison, Alexander H., et al.
Publicado: (2019)

Tocilizumab Evaluation in HLA-Desensitization before Kidney Transplantation as an Add-On Therapy to Apheresis: The TETRA Study
por: Jouve, Thomas, et al.
Publicado: (2023)

Optimizing donor scheduling before recruitment: An effective approach to increasing apheresis platelet collections
por: Lokhandwala, Parvez M., et al.
Publicado: (2018)

Effect of Frequency of Platelet Apheresis on Coagulation Function in Donors: A Prospective Cohort Study
por: Feng, Qing, et al.
Publicado: (2019)

The safety of plasma apheresis from donors recovering from COVID-19 infection in Japan
por: Kamo-Imai, Ayumi, et al.
Publicado: (2023)

Natural soluble human leukocyte antigen class I in donor serum neutralizes donor-specific HLA alloantibodies in recipient serum
por: Won, Dong Il, et al.
Publicado: (2020)

Apheresis in Neurological Disorders
por: Dorst, Johannes
Publicado: (2020)

Apheresis and Covid-19
por: Griveas, Ioannis
Publicado: (2022)

Glomerulocapillary miRNA response to HLA-class I antibody in vitro and in vivo
por: Heinemann, Falko M., et al.
Publicado: (2017)

Differential effects of donor‐specific HLA antibodies in living versus deceased donor transplant
por: Kamburova, E. G., et al.
Publicado: (2018)

Donor specific HLA antibody in hematopoietic stem cell transplantation: Implications for donor selection
por: Krummey, Scott M., et al.
Publicado: (2022)

Clinical Relevance of Pretransplant HLA Class II Donor-specific Antibodies in Renal Transplantation Patients with Negative T-cell Cytotoxicity Crossmatches
por: Song, Eun Young, et al.
Publicado: (2012)

Impact of preformed donor-specific antibodies against HLA class I on kidney graft outcomes: Comparative analysis of exclusively anti-Cw vs anti-A and/or -B antibodies
por: Santos, Sofia, et al.
Publicado: (2016)

Prevalence and risk factors of antibodies towards HLA Class I and Class II in Malaysian renal transplant candidates
por: Khairul-Fahmy, Norfarhana, et al.
Publicado: (2023)

Agaricus blazei-Based Mushroom Extract Supplementation to Birch Allergic Blood Donors: A Randomized Clinical Trial
por: Mahmood, Faiza, et al.
Publicado: (2019)

Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics
por: Nagler, Adi, et al.
Publicado: (2021)

Living Donor Kidney Transplantation in Patients With Donor-Specific HLA Antibodies After Desensitization With Immunoadsorption
por: Kälble, Florian, et al.
Publicado: (2021)

Non-invasive screening for subclinical liver graft injury in adults via donor-specific anti-HLA antibodies
por: Höfer, Anne, et al.
Publicado: (2020)

Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab
por: Garrido, Greta, et al.
Publicado: (2017)

Association of HLA-A and Non-Classical HLA Class I Alleles
por: Carlini, Federico, et al.
Publicado: (2016)

Therapeutic apheresis in autoimmune diseases
por: Bambauer, Rolf, et al.
Publicado: (2013)

Therapeutic Apheresis in Metabolic Syndrome
por: Voinov, V.A.
Publicado: (2018)

Familial Hypercholesterolemia and Lipoprotein Apheresis
por: Makino, Hisashi, et al.
Publicado: (2019)

Current Role of Lipoprotein Apheresis
por: Thompson, Gilbert, et al.
Publicado: (2019)

HLA class II donor specific antibodies are associated with graft cirrhosis after liver transplant independent of the mean fluorescence intensity level
por: Willuweit, Katharina, et al.
Publicado: (2020)

Factors associated with vasovagal reactions in apheresis plasma and whole blood donors: a statistical-epidemiological study in a European donor cohort
por: Seheult, Jansen N., et al.
Publicado: (2016)

Prolonged sinus arrest on electrocardiogram recording during apheresis donation in young female donor with convulsive syncope
por: Nakai, Kenji, et al.
Publicado: (2019)

Safe Blood Donation from Donors Using Antihypertensive Medication. A Multi-Center Retrospective Quality Study from South-East Norway
por: Johnsen, Kathrine M Neuman, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lhjb5a4upnk2c6om2rmvibqj95